Moderna

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Moderna and other ETFs, options, and stocks.

About MRNA

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.

CEO

Stéphane Bancel

CEOStéphane Bancel

Employees

5,600

Employees5,600

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2010

Founded2010

Employees

5,600

Employees5,600

MRNA Key Statistics

Market cap

15.24B

Market cap15.24B

Price-Earnings ratio

-6.80

Price-Earnings ratio-6.80

Dividend yield

—

Dividend yield—

Average volume

9.72M

Average volume9.72M

High today

$40.34

High today$40.34

Low today

$38.52

Low today$38.52

Open price

$39.49

Open price$39.49

Volume

5.11M

Volume5.11M

52 Week high

$170.47

52 Week high$170.47

52 Week low

$35.80

52 Week low$35.80

MRNA News

Simply Wall St 2d

While Moderna shareholders have made 102% in 5 years, increasing losses might now be front of mind as stock sheds 5.8% this week

Some Moderna, Inc. ( ) shareholders are probably rather concerned to see the share price fall 39% over the last three months. But that scarcely detracts from th...

TipRanks 5d

Personalis receives $50M investment from Merck, extends pact with Moderna

Personalis (PSNL) announced agreements with long time collaborators Merck (MRK) and Moderna (MRNA) that accelerate the advancement of the company’s business str...

Analyst ratings

50%

of 28 ratings

Buy

35.7%

Hold

50%

Sell

14.3%